Skip to content

Dr. Barry Dworkin

  • About
  • Radio Interviews
    • Wednesday House Call
    • Sunday House Call Shows
  • Articles
    • Health Headlines
    • Prevention and Screening
    • Clinical Research
    • Health Policy
    • Cancer/Oncology
    • Neurology
  • UBC, Université de Sherbrooke, and Cornell University researchers report a new enzyme-blocking compound delivered in a nasal spray that effectively treats delta variant infection in mice. Human trials dependent on securing funding.

    March 29, 2022

    Medical Mythbusting Commentary for March 29, 2022 Source:New compound delivered in a nasal spray effectively treats delta variant infection in mice Reference:A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic

  • Facebook
  • X

Notifications